Your browser is no longer supported. Please, upgrade your browser.
Settings
CBMG Cellular Biomedicine Group, Inc. daily Stock Chart
CBMG [NASD]
Cellular Biomedicine Group, Inc.
Index- P/E- EPS (ttm)-2.21 Insider Own0.80% Shs Outstand20.57M Perf Week-1.12%
Market Cap308.34M Forward P/E- EPS next Y-1.97 Insider Trans0.00% Shs Float12.46M Perf Month-13.10%
Income-39.80M PEG- EPS next Q-0.53 Inst Own23.80% Short Float4.32% Perf Quarter-10.19%
Sales0.20M P/S1541.72 EPS this Y24.10% Inst Trans37.45% Short Ratio15.23 Perf Half Y-11.56%
Book/sh5.10 P/B2.94 EPS next Y5.70% ROA-38.70% Target Price32.00 Perf Year-16.95%
Cash/sh- P/C- EPS next 5Y- ROE-45.60% 52W Range12.04 - 25.00 Perf YTD-15.12%
Dividend- P/FCF- EPS past 5Y-2.30% ROI-47.50% 52W High-40.04% Beta2.52
Dividend %- Quick Ratio4.40 Sales past 5Y1.80% Gross Margin45.40% 52W Low24.50% ATR0.85
Employees193 Current Ratio4.40 Sales Q/Q-3.30% Oper. Margin- RSI (14)45.31 Volatility4.73% 5.97%
OptionableYes Debt/Eq0.07 EPS Q/Q-1.40% Profit Margin- Rel Volume0.35 Prev Close14.99
ShortableYes LT Debt/Eq0.00 EarningsJul 30 BMO Payout- Avg Volume35.32K Price14.99
Recom1.50 SMA20-2.79% SMA50-7.96% SMA200-14.56% Volume12,315 Change0.00%
Feb-07-19Initiated Robert W. Baird Outperform
Mar-08-18Initiated B. Riley FBR, Inc. Buy $32
Feb-01-18Downgrade Maxim Group Buy → Hold
Nov-29-16Reiterated Maxim Group Buy $16 → $18
Sep-22-16Initiated Maxim Group Buy $16
Jun-18-19 07:30AM  ­Cellular Biomedicine Group Executives to Present at CAR-TCR Summit Asia PR Newswire -5.01%
Jun-17-19 07:00AM  Cellular Biomedicine Group Announces First Patient Dosing in Phase I Clinical Trial of Anti-CD20 CAR-T for Lymphoma in China PR Newswire
May-29-19 08:45AM  Cellular Biomedicine Group to Present at International Society for Cell and Gene Therapy Annual Meeting PR Newswire
May-20-19 08:00AM  Cellular Biomedicine Group to Present at B. Riley FBR Annual Investor Conference PR Newswire
May-17-19 12:04PM  Do Directors Own Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) Shares? Simply Wall St.
May-07-19 05:51PM  Edited Transcript of CBMG earnings conference call or presentation 1-May-19 12:30pm GMT Thomson Reuters StreetEvents
Apr-30-19 07:40PM  Cellular Biomedicine: 1Q Earnings Snapshot Associated Press
05:24PM  Cellular Biomedicine Group Reports First Quarter 2019 Results and Highlights Operational Progress PR Newswire
Apr-29-19 09:00AM  Cellular Biomedicine Group Announces Results of 2019 Annual Meeting of Stockholders PR Newswire
Apr-25-19 09:00AM  Cellular Biomedicine Group to Report First Quarter 2019 Results and Host Conference Call on May 1, 2019 PR Newswire
Apr-23-19 08:30AM  Cellular Biomedicine Group Upgraded to NASDAQ Global Select Market PR Newswire
Apr-15-19 09:20AM  Cellular Biomedicine Group to Participate in Asia Pharma R&D Leaders Summit 2019 PR Newswire
Apr-05-19 09:00AM  Cellular Biomedicine Group to Present at Annual BioCentury Future Leaders in the Biotech Industry Conference PR Newswire
Apr-03-19 04:39PM  SHAREHOLDER ALERT: Monteverde & Associates PC Launches an Investigation of the Board of Directors and Officers PR Newswire
02:57PM  Our Take On Cellular Biomedicine Group, Inc.'s (NASDAQ:CBMG) CEO Salary Simply Wall St.
Mar-28-19 09:00AM  Cellular Biomedicine Group (CBMG) Announces Annual Meeting of Stockholders PR Newswire
Mar-21-19 08:58AM  Cellular Biomedicine Group Announces Pricing of Public Offering of Common Stock PR Newswire -6.76%
07:51AM  The Daily Biotech Pulse: Biogen Plummets, FDA Greenlights Sleep Disorder Drug, Cellular Biomedicine Offering Benzinga
Mar-20-19 04:01PM  Cellular Biomedicine Group Announces Proposed Follow-on Offering of Common Stock PR Newswire
Feb-27-19 06:53PM  Cellular Biomedicine Group to Present at 8th Annual SVB Leerink Global Healthcare Conference PR Newswire
Feb-20-19 08:45AM  Cellular Biomedicine Group (CBMG) Reports Q4 Loss, Lags Revenue Estimates Zacks -14.13%
Feb-19-19 07:58PM  Cellular Biomedicine Group Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Operational Progress PR Newswire
Feb-12-19 02:20PM  Should You Be Holding Cellular Biomedicine Group, Inc. (NASDAQ:CBMG)? Simply Wall St.
Jan-17-19 06:00AM  Cellular Biomedicine Group's AlloJoin® Therapy for Knee Osteoarthritis (KOA) Becomes the First Stem Cell Drug Application Approved in China for Phase II Clinical Trials PR Newswire +7.94%
Jan-08-19 07:30PM  Cellular Biomedicine Group Initiates Patient Recruitment for Clinical Trial in B Cell Maturation Antigen (Anti-BCMA) Chimeric Antigen Receptor T-Cell (CAR-T) Therapy Targeting Multiple Myeloma (MM) PR Newswire
Dec-26-18 06:38AM  What Investors Should Know About Cellular Biomedicine Group, Inc.s (NASDAQ:CBMG) Financial Strength Simply Wall St. +11.53%
Dec-18-18 07:30AM  Cellular Biomedicine Group Appoints CAR-T Pioneer Dr. Stephan A. Grupp as Member of Scientific Advisory Board GlobeNewswire
Nov-16-18 08:50AM  Investor Expectations to Drive Momentum within ANGI Homeservices, Aytu Bioscience, IRIDEX, Cellular Biomedicine Group, CounterPath, and EXFO Discovering Underlying Factors of Influence GlobeNewswire
Nov-06-18 09:35AM  Cellular Biomedicine Group (CBMG) Reports Q3 Loss, Tops Revenue Estimates Zacks
08:29AM  Cellular Biomedicine: 3Q Earnings Snapshot Associated Press
06:56AM  Cellular Biomedicine Group Reports Third Quarter Financial Results and Recent Business Highlights GlobeNewswire
Nov-01-18 11:28AM  Earnings Preview: Cellular Biomedicine Group (CBMG) Q3 Earnings Expected to Decline Zacks +11.48%
Oct-25-18 08:56AM  Cellular Biomedicine Group to Provide Company Cancer Immunotherapy Pipeline Update and Facility Tour for Attendees of the Advanced Cell Therapy Summit in Shanghai GlobeNewswire
Sep-27-18 02:41PM  [$$] Cellular Biomedicine, Novartis in CAR-T Cell Therapy Pact The Wall Street Journal -6.58%
01:34PM  Novartis strikes deal with Chinese firm to make Kymriah Reuters
07:30AM  Cellular Biomedicine Group Enters Into Strategic Licensing and Collaboration Agreement with a Global Leader in CAR-T Cell Therapy for Patients in China PR Newswire
Sep-24-18 03:30PM  Who Are The Top Investors In Cellular Biomedicine Group Inc (NASDAQ:CBMG)? Simply Wall St.
08:15AM  Cellular Biomedicine Group to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference GlobeNewswire
Aug-28-18 09:16AM  Cellular Biomedicine Group to Present on Three Panels at B. Riley FBR Annual Healthcare Conference GlobeNewswire
Aug-08-18 08:50AM  Cellular Biomedicine Group (CBMG) Reports Q2 Loss, Tops Revenue Estimates Zacks
07:46AM  Cellular Biomedicine: 2Q Earnings Snapshot Associated Press
07:31AM  Cellular Biomedicine Group Reports Second Quarter and First Half 2018 Financial Results and Business Highlights GlobeNewswire
Jul-20-18 09:30AM  Stem-Cell Investments on the Rise ACCESSWIRE +7.00%
Jun-22-18 09:00AM  Cellular Biomedicine Group Announces Grand Opening of Global Research and Development Center in Gaithersburg, Maryland GlobeNewswire +12.47%
Jun-21-18 07:30AM  Cellular Biomedicine Group to Present a Keynote Address at CAR-TCR Summit Asia GlobeNewswire
May-08-18 06:00AM  Cellular Biomedicine Group Reports First Quarter 2018 Financial Results and Highlights Operational Progress GlobeNewswire
05:08AM  Cellular Biomedicine: 1Q Earnings Snapshot Associated Press
May-07-18 10:51AM  Should You Be Content With Cellular Biomedicine Group Incs (NASDAQ:CBMG) Earnings Growth? Simply Wall St. -5.66%
Apr-30-18 08:30AM  Cellular Biomedicine Group Announces Results of 2018 Annual Meeting of Stockholders GlobeNewswire
Mar-23-18 07:00AM  Cellular Biomedicine Group (CBMG) Announces Annual Meeting of Stockholders GlobeNewswire
Mar-20-18 07:40AM  Wired News Cellular Biomedicine's 48-Week Data off China-based Phase-I Clinical Trial Shows Positive Result for AlloJoin(TM) for Treatment of KOA ACCESSWIRE
Mar-16-18 07:00AM  Cellular Biomedicine Group Announces Positive 48-Week Clinical Data of AlloJoin Human Adipose-Derived Mesenchymal Progenitor Cell (haMPC) Knee Osteoarthritis (KOA) China Phase I Trial GlobeNewswire
Mar-06-18 09:44AM  Cellular Biomedicine reports 4Q loss Associated Press
09:27AM  Cellular Biomedicine Group Reports Full-Year 2017 Financial Results and Recent Operational Progress GlobeNewswire
Mar-01-18 09:15AM  Cellular Biomedicine Group Invited to Present a Keynote Speech at Phar-East Asia Pharma & Biotech Festival GlobeNewswire +10.10%
Feb-05-18 08:18AM  Cellular Biomedicine Group Announces $30.6 million Investment from Sailing Capital Overseas Investment Ltd. GlobeNewswire
Jan-19-18 08:43PM  CBMG Accelerates Cell Therapy Manufacturing with GE Healthcares New Start-to-Finish Solution GlobeNewswire
Jan-18-18 04:15PM  CBMG Accelerates Cell Therapy Manufacturing with GE Healthcares New Start-to-Finish Solution GlobeNewswire
Dec-28-17 11:55AM  ETFs with exposure to Cellular Biomedicine Group, Inc. : December 28, 2017 Capital Cube +11.17%
07:30AM  Cellular Biomedicine Group Announces Closing of $14.5 Million Private Placement Offering GlobeNewswire
Dec-27-17 08:46AM  Cellular Biomedicine Group, Inc. :CBMG-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017 Capital Cube
Nov-09-17 08:45AM  Cellular Biomedicine reports 3Q loss Associated Press
08:30AM  Cellular Biomedicine Group Reports Third Quarter Financial Results and Recent Operational Highlights GlobeNewswire
Nov-07-17 06:00AM  Cellular Biomedicine Group Opens its New Shanghai GMP Facility and Joint Laboratory GlobeNewswire
Nov-06-17 07:20AM  Thermo Fisher Scientific and Cellular Biomedicine Group Announce Strategic Partnership to Develop Manufacturing Processes GlobeNewswire
Oct-31-17 08:00AM  Cellular Biomedicine Group Executives to Present at Biotech and Money World HealthEx Forum in London GlobeNewswire +8.67%
Sep-22-17 08:40AM  Cellular Biomedicine Group Plans Grand Opening of its New Shanghai Facility GlobeNewswire
Sep-20-17 01:51PM  One Thing To Consider Before Buying Cellular Biomedicine Group Inc (CBMG) Simply Wall St.
Sep-19-17 06:30AM  BioLife Solutions CryoStor® Cell Freeze Media Embedded in Cellular Biomedicine Group Clinical Trial of AlloJoin PR Newswire
Sep-14-17 08:30AM  Cellular Biomedicine Group to Present at the Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-05-17 08:27PM  ETFs with exposure to Cellular Biomedicine Group, Inc. : September 6, 2017 Capital Cube +5.56%
Aug-24-17 10:32AM  Cellular Biomedicine Group, Inc. :CBMG-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017 Capital Cube
Aug-18-17 08:45AM  Streetwise Reports Examines One Regenerative Medicine Firm to 'Keep a Close Eye On' Marketwired
Aug-08-17 11:54PM  Cellular Biomedicine reports 2Q loss Associated Press
04:31PM  Cellular Biomedicine Group Reports Second Quarter and First Half 2017 Financial Results and Business Highlights GlobeNewswire
Jul-11-17 02:13PM  ETFs with exposure to Cellular Biomedicine Group, Inc. : July 11, 2017 Capital Cube
Jun-26-17 07:28AM  Cellular Biomedicine Group (CBMG) Appoints Dr. Xia Meng as Chief Operating Officer to Lead Commercialization of the Companys CAR-T and Stem Cell Products GlobeNewswire
Jun-20-17 06:00AM  Cellular Biomedicine Group Appoints Michael A. Caligiuri, MD as Chair of External Advisory Board GlobeNewswire
Jun-05-17 02:07PM  ETFs with exposure to Cellular Biomedicine Group, Inc. : June 5, 2017 Capital Cube
Jun-02-17 09:39AM  Cellular Biomedicine Group, Inc. :CBMG-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017 Capital Cube
Jun-01-17 06:00AM  Cellular Biomedicine Group (CBMG) Announces Stock Repurchase Program GlobeNewswire
May-19-17 08:28AM  Cellular Biomedicine Group (CBMG) Announces Publication Titled Target cell killing effects of CD20 targeting chimeric antigen receptor T cells derived from the type II anti-CD20 antibody in Conjunction with 2017 ASCO Annual Meeting GlobeNewswire
May-15-17 06:23AM  Cellular Biomedicine Group (CBMG) Announces the Addition of a Second Clinical Site in the Expansion of its Chimeric Antigen Receptor T-cell (CAR-T) Phase I Clinical Trial for Its CARD-1 Trial in Patients with Non-Hodgkin Lymphoma (NHL) GlobeNewswire
May-08-17 05:30PM  Cellular Biomedicine reports 1Q loss Associated Press
04:01PM  Cellular Biomedicine Group Reports First Quarter 2017 Financial Results and Provides Business Highlights GlobeNewswire
May-01-17 04:01PM  Cellular Biomedicine Group Announces Results of 2017 Annual Meeting of Stockholders GlobeNewswire
Apr-11-17 09:01AM  GE Collaborates with CBMG to Enhance Healthcare Portfolio Zacks
Apr-10-17 01:34PM  Cellular Biomedicine and GE Healthcare Ink Pact Investopedia
08:49AM  Cellular Biomedicine Group (CBMG) and GE Healthcare Life Sciences China Announce Strategic Partnership to Establish Joint Technology Laboratory to Develop Control Processes... GlobeNewswire
08:05AM  Cellular Biomedicine Group (CBMG) and GE Healthcare Life Sciences China Announce Strategic Partnership to Establish Joint Technology Laboratory to Develop Control Processes for the Manufacture of CAR-T and Stem Cell Therapies GlobeNewswire
Mar-30-17 08:49AM  Cellular Biomedicine Group (CBMG) Announces Completion of Wuxi GMP Facility Expansion GlobeNewswire
Mar-23-17 12:21PM  Cellular Biomedicine Group, Inc. :CBMG-US: Earnings Analysis: Q4, 2016 By the Numbers : March 23, 2017 Capital Cube
12:21PM  Cellular Biomedicine Group, Inc. :CBMG-US: Earnings Analysis: Q4, 2016 By the Numbers : March 23, 2017
Mar-22-17 11:13AM  Cellular Biomedicine Group, Inc. :CBMG-US: Earnings Analysis: 2016 By the Numbers : March 22, 2017
Mar-21-17 08:15AM  Cellular Biomedicine Group (CBMG) Announces Annual Meeting of Stockholders GlobeNewswire
Mar-18-17 01:04PM  CELLULAR BIOMEDICINE GROUP, INC. Financials
Mar-16-17 11:36AM  Cellular Biomedicine Group Inc (CBMG) Expands GMP Capacity For The Growing Chinese Market Insider Monkey
11:36AM  Cellular Biomedicine Group Inc (CBMG) Expands GMP Capacity For The Growing Chinese Market at Insider Monkey
Mar-14-17 04:14PM  CELLULAR BIOMEDICINE GROUP, INC. Files SEC form 10-K/A, Annual Report
06:32AM  Cellular Biomedicine reports 4Q loss Associated Press
Cellular Biomedicine Group, Inc., a clinical stage biopharmaceutical company, develops therapies for cancer and degenerative diseases in Greater China. It focuses on developing and marketing cell-based therapies to treat various diseases, such as cancer and orthopedic diseases. The company develops treatments utilizing proprietary cell based technologies, including immune cell therapy for treating a range of cancer indications comprising technologies in chimeric antigen receptor modified T cells (CAR-T), a genetically modified T-cell receptors (TCRs), and next generation neoantigen-reactive tumor infiltrating lymphocytes; and human adipose-derived mesenchymal progenitor cells for the treatment of joint diseases. The company's CAR-T products include CD20 for use in anti-tumor activities; CD22, a surface maker highly expressed in B cell malignancies in hairy cell leukemia; and B-cell maturation antigen therapies for treating refractory multiple myeloma in patients. It also develops NKG2D CAR therapies for use in NK cell signaling; alpha fetoprotein TCR-T therapies for treating hepatocellular carcinoma; tumor infiltrating lymphocyte therapies for treating immunogenic cancers; and knee osteoarthritis therapies, including AlloJoin therapy, which is in a Phase I clinical trial, as well as Re-Join that has completed the Phase IIb clinical trial. In addition, it engages in biopharmaceutical businesses, including research and development, technical support, technical service, and technology transfer activities in biomedical technology field; manufacturing non-food, pharmaceutical polypeptides, and medical devices; and the wholesale of cosmetics, sanitary products, and biological agents. The company has a strategic licensing and collaboration agreement with Novartis Pharma AG to manufacture and supply their CAR-T cell therapy Kymriah in China. Cellular Biomedicine Group, Inc. was incorporated in 2001 and is headquartered in New York, New York.